Our mission is to improve lives by redefining how medicines are delivered and experienced.
We are a drug delivery and development company with a propietary formulation and delivery platform. Based in the U.S., we are a vertically-integrated oral thin film manufacturer, and our marquis technology is CUREfilm®, an oral dissolvable film. Our innovative oral thin film formulation makes medications easier to take, more efficacious, and with fewer tolerability and side effects.
People-First Solutions
We are motivated to improve patient experiences. Our technology offers patients a proven alternative to pills and injections and they benefit from improved delivery of actives for faster clinical effect and symptom relief.
Collaborative Partnerships
We understand your business goals and work collaboratively with you to address common pain points in order to deliver sustainable solutions and improved experiences for your customers.
Purpose-Driven Mission
We’re on a mission to make medications easier to take, more efficacious, and with increased tolerability and fewer side effects. When the burden of taking medication is eliminated, patient adherence increases.
Learn more about how we can help you with more efficient drug delivery technology in nutraceuticals, pharmaceuticals and cannabinoids.
Latest News
CURE Pharmaceutical Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions
October 09, 2019
Alternative dosage demand drives company’s manufacturing expansion OXNARD, Calif., Oct. 09, 2019...READ MORE
Latest News
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
September 27, 2019
Biopharma star brings extensive translational research experience as company advances its clinical...READ MORE
Latest News
CURE Pharmaceutical Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
August 21, 2019
OXNARD, Calif. – August 21, 2019 - CURE Pharmaceutical (OTC: CURR), an innovative drug delivery...READ MORE
Read Our Blog
Rob Davidson on Cannabis Radio: Innovative Drug Delivery And Development
October 01, 2019
Our CEO, Rob Davidson sat down for a chat with Cannabis Radio to discuss the particular advantages of our...READ MORE
Read Our Blog
PharmaVoice Woman of the Week Podcast features Jessica Rousset, Chief Operating Officer, CURE
June 04, 2019
This podcast and transcript are republished with permission from PharmaVoice. --------------...READ MORE
Read Our Blog
FAQs: CURE Pharmaceutical to Acquire Chemistry Holdings Inc.,
April 03, 2019
On Monday, April 1, we announced our plans to acquire Chemistry Holdings, a formulation technology company...READ MORE